Uniqure gene therapy for Huntington’s slowed disease progression in key trial | NYGazet

Results are likely to support the first approval of a genetic treatment for the rare neurodegenerative condition.

An experimental gene therapy from Uniqure slowed the progression of Huntington’s disease by 75% after three years — study results reported Wednesday that are likely to support the first approval of a genetic treatment for the rare neurodegenerative c... [286 chars]